<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">detinf</journal-id><journal-title-group><journal-title xml:lang="ru">ДЕТСКИЕ ИНФЕКЦИИ</journal-title><trans-title-group xml:lang="en"><trans-title>CHILDREN INFECTIONS</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-8107</issn><issn pub-type="epub">2618-8139</issn><publisher><publisher-name>Association of Pediatricians and Infection Disease doctors</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.22627/2072-8107-2023-22-1-45-49</article-id><article-id custom-type="elpub" pub-id-type="custom">detinf-813</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОР ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW OF THE LITERATURE</subject></subj-group></article-categories><title-group><article-title>Вакцинация детей против COVID-19: зарубежный опыт (обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>Vaccination of children against COVID-19: foreign experience (literature review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3865-2234</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Буфетова</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Bufetova</surname><given-names>A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Буфетова Анастасия Михайловна, студент</p><p>г. Киров</p></bio><bio xml:lang="en"><p>Bufetova A.</p><p>Kirov</p></bio><email xlink:type="simple">nastya.bufetova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8760-4306</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вишняков</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vishnyakov</surname><given-names>A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Вишняков Алексей Васильевич, студент</p><p>г. Киров</p></bio><bio xml:lang="en"><p>Vishnyakov А.</p><p>Kirov</p></bio><email xlink:type="simple">mishakrossingover@gmail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8610-7292</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горелов</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Gorelov</surname><given-names>E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Горелов Егор Николаевич, студент</p><p>г. Киров</p></bio><bio xml:lang="en"><p>Gorelov Е.</p><p>Kirov</p></bio><email xlink:type="simple">Egor1Gorelov@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6849-2572</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Леушина</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Leushina</surname><given-names>E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Леушина Елизавета Сергеевна, студент</p><p>г. Киров</p></bio><bio xml:lang="en"><p>Leushina Е.</p><p>Kirov</p></bio><email xlink:type="simple">liza.leushina.99@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7587-3437</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Утенкова</surname><given-names>Е. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Utenkova</surname><given-names>E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Утенкова Елена Олеговна, д.м.н., профессор кафедры инфекционных болезней</p><p>г. Киров</p></bio><bio xml:lang="en"><p>Utenkova Е., MD</p><p>Kirov</p></bio><email xlink:type="simple">utelol@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Кировский государственный медицинский университет<country>Россия</country></aff><aff xml:lang="en">Kirov state medical university<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>01</day><month>04</month><year>2023</year></pub-date><volume>22</volume><issue>1</issue><fpage>45</fpage><lpage>49</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Буфетова А.М., Вишняков А.В., Горелов Е.Н., Леушина Е.С., Утенкова Е.О., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Буфетова А.М., Вишняков А.В., Горелов Е.Н., Леушина Е.С., Утенкова Е.О.</copyright-holder><copyright-holder xml:lang="en">Bufetova A., Vishnyakov A., Gorelov E., Leushina E., Utenkova E.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://detinf.elpub.ru/jour/article/view/813">https://detinf.elpub.ru/jour/article/view/813</self-uri><abstract><p>Необходимость вакцинации детей в возрасте до 12 лет против COVID-19 на сегодняшний день остается объектом дискуссии. Относительно низкий риск, связанный с инфекцией у детей и неоднозначные выводы при сопоставлении последствий вакцинации и перенесенного заболевания являются основанием полагать, что соотношение риска и пользы вакцинации в данной возрастной группе является спорным решением. Одним из ключевых аргументов в пользу вакцинации здоровых детей является защита их от долгосрочных последствий COVID-19. Кроме того, следует принимать во внимание такие социально значимые факторы, как снижение распространения инфекции, затраты на поставки вакцины или же ущерб, связанный с организацией карантинных мероприятий (в том числе закрытием школ и переводом образовательного процесса в дистанционный формат). Динамика ситуации требует постоянной переоценки риска и пользы специфической профилактики у детей. Целью данного литературного обзора является систематизация объективных данных, касающихся зарубежного опыта вакцинации детей от COVID-19, аргументов за и против вакцинации, которые осложняют принятие решение по исследуемому вопросу на том или ином уровне.</p></abstract><trans-abstract xml:lang="en"><p>The need to vaccinate children under the age of 12 against COVID-19 remains an object of discussion today. The relatively low risk associated with infection in children and the ambiguous conclusions when comparing the effects of vaccination and the transferred disease are grounds to believe that the ratio of risk and benefit of vaccination in this age group is more complex. One of the key arguments in favor of vaccinating healthy children is to protect them from the long-term effects of COVID-19. In addition, socially significant factors such as a decrease in the spread of infection, the cost of vaccine supplies or damage associated with the organization of quarantine measures (including the closure of schools and the transfer of the educational process to a remote format) should be taken into account. The dynamics of the situation requires a constant reassessment of the risk and benefits of specific prevention in children. The purpose of this literature review is to systematize objective data concerning the foreign experience of vaccination of children against COVID-19; arguments for and against vaccination, which complicate the decision-making on the issue under study at one level or another.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>вакцинация</kwd><kwd>COVID-19</kwd><kwd>дети</kwd></kwd-group><kwd-group xml:lang="en"><kwd>vaccination</kwd><kwd>COVID-19</kwd><kwd>children</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Govender K, Nyamaruze P, McKerrow N, Meyer-Weitz A, Cowden RG. COVID-19 vaccines for children and adolescents in Africa: aligning our priorities to situational realities. BMJ Glob Health. 2022 Feb; 7(2):e007839. doi:10.1136/bmjgh-2021-007839.</mixed-citation><mixed-citation xml:lang="en">Govender K, Nyamaruze P, McKerrow N, Meyer-Weitz A, Cowden RG. COVID-19 vaccines for children and adolescents in Africa: aligning our priorities to situational realities. BMJ Glob Health. 2022 Feb; 7(2):e007839. doi:10.1136/bmjgh-2021-007839.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kraaijeveld, Steven R. ; Gur-Arie, Rachel &amp; Jamrozik, Euzebiusz (2022). Against COVID-19 vaccination of healthy children. Bioethics. 36(6):687—698.</mixed-citation><mixed-citation xml:lang="en">Kraaijeveld, Steven R. ; Gur-Arie, Rachel &amp; Jamrozik, Euzebiusz (2022). Against COVID-19 vaccination of healthy children. Bioethics. 36(6):687—698.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Götzinger F, Santiago-García B, Noguera-Julián A, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020; 4:653—61. doi:10.1016/S2352-4642(20)30177-2</mixed-citation><mixed-citation xml:lang="en">Götzinger F, Santiago-García B, Noguera-Julián A, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020; 4:653—61. doi:10.1016/S2352-4642(20)30177-2</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020; 39:355—68. doi:10.1097/INF.0000000000002660</mixed-citation><mixed-citation xml:lang="en">Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020; 39:355—68. doi:10.1097/INF.0000000000002660</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Castagnoli R, Votto M, Licari A, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr. 2020; 174:882—9. doi:10.1001/jamapediatrics.2020.1467</mixed-citation><mixed-citation xml:lang="en">Castagnoli R, Votto M, Licari A, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr. 2020; 174:882—9. doi:10.1001/jamapediatrics.2020.1467</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109:1088—95. doi:10.1111/apa.15270</mixed-citation><mixed-citation xml:lang="en">Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109:1088—95. doi:10.1111/apa.15270</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zimmermann P, Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child. 2021; 106:429—39. doi:10.1136/archdischild-2020-320338</mixed-citation><mixed-citation xml:lang="en">Zimmermann P, Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child. 2021; 106:429—39. doi:10.1136/archdischild-2020-320338</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zimmermann P, Curtis N. COVID-19 in children, pregnancy and neonates: a review of epidemiologic and clinical features. Pediatr Infect Dis J. 2020; 39:469—77. doi:10.1097/INF.0000000000002700</mixed-citation><mixed-citation xml:lang="en">Zimmermann P, Curtis N. COVID-19 in children, pregnancy and neonates: a review of epidemiologic and clinical features. Pediatr Infect Dis J. 2020; 39:469—77. doi:10.1097/INF.0000000000002700</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Uka A, Buettcher M, Bernhard-Stirnemann S. Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study. Eur J Pediatr. 2021.</mixed-citation><mixed-citation xml:lang="en">Uka A, Buettcher M, Bernhard-Stirnemann S. Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study. Eur J Pediatr. 2021.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ward JL, Harwood R, Smith C. Risk factors for intensive care admission and death amongst children and young people admitted to hospital with COVID-19 and PIMS-TS in England during the first pandemic year. МedRxiv. 2021:2021.07.01.21259785.</mixed-citation><mixed-citation xml:lang="en">Ward JL, Harwood R, Smith C. Risk factors for intensive care admission and death amongst children and young people admitted to hospital with COVID-19 and PIMS-TS in England during the first pandemic year. МedRxiv. 2021:2021.07.01.21259785.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus Disease 2019 Case Surveillance — United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69:759—65. doi:10.15585/mmwr.mm6924e2</mixed-citation><mixed-citation xml:lang="en">Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus Disease 2019 Case Surveillance — United States, January 22-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69:759—65. doi:10.15585/mmwr.mm6924e2</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020; 382:1663—5. doi:10.1056/NEJMc2005073</mixed-citation><mixed-citation xml:lang="en">Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020; 382:1663—5. doi:10.1056/NEJMc2005073</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bhuiyan MU, Stiboy E, Hassan MZ, et al. Epidemiology of COVID-19 infection in young children under five years: a systematic review and meta-analysis. Vaccine. 2021; 39:667—77. doi:10.1016/j.vaccine.2020.11.078</mixed-citation><mixed-citation xml:lang="en">Bhuiyan MU, Stiboy E, Hassan MZ, et al. Epidemiology of COVID-19 infection in young children under five years: a systematic review and meta-analysis. Vaccine. 2021; 39:667—77. doi:10.1016/j.vaccine.2020.11.078</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Pegden W, Prasad V, Baral S. Covid vaccines for children should not get emergency use Authorization. The BMJ opinion, 2021. Available: https://blogs.bmj.com/bmj/2021/05/07/covid-vaccines-forchildren-should-not-get-emergency-use-authorization/</mixed-citation><mixed-citation xml:lang="en">Pegden W, Prasad V, Baral S. Covid vaccines for children should not get emergency use Authorization. The BMJ opinion, 2021. Available: https://blogs.bmj.com/bmj/2021/05/07/covid-vaccines-forchildren-should-not-get-emergency-use-authorization/</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Fernandes DM, Oliveira CR, Guerguis S, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Clinical Syndromes and Predictors of Disease Severity in Hospitalized Children and Youth. J Pediatr. 2021; 230:e10:23—31. doi:10.1016/j.jpeds.2020.11.016</mixed-citation><mixed-citation xml:lang="en">Fernandes DM, Oliveira CR, Guerguis S, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Clinical Syndromes and Predictors of Disease Severity in Hospitalized Children and Youth. J Pediatr. 2021; 230:e10:23—31. doi:10.1016/j.jpeds.2020.11.016</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">National Centre for Immunisation Research and Surveillance NCIRS. COVID-19 delta variant in schools and early childhood education and care services in NSW, Australia: 16 June to 31 July 2021. Available: https://www.ncirs.org.au/sites/default/files/2021-09/NCIRS%20NSW%20Schools%20COVID_Summary_8%20September%2021_Final.pdf [Accessed 9 Sep 2021].</mixed-citation><mixed-citation xml:lang="en">National Centre for Immunisation Research and Surveillance NCIRS. COVID-19 delta variant in schools and early childhood education and care services in NSW, Australia: 16 June to 31 July 2021. Available: https://www.ncirs.org.au/sites/default/files/2021-09/NCIRS%20NSW%20Schools%20COVID_Summary_8%20September%2021_Final.pdf [Accessed 9 Sep 2021].</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Harris RJ, Hall JA, Zaidi A, et al. Effect of vaccination on household transmission of SARS-CoV-2 in England. N Engl J Med. 2021; 385:759—60. doi:10.1056/NEJMc2107717</mixed-citation><mixed-citation xml:lang="en">Harris RJ, Hall JA, Zaidi A, et al. Effect of vaccination on household transmission of SARS-CoV-2 in England. N Engl J Med. 2021; 385:759—60. doi:10.1056/NEJMc2107717</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Levine-Tiefenbrun M, Yelin I, Katz R. Decreased SARS-CoV-2 viral load following vaccination. МedRxiv. 2021. doi:10.1101/2021.02.06.21251283</mixed-citation><mixed-citation xml:lang="en">Levine-Tiefenbrun M, Yelin I, Katz R. Decreased SARS-CoV-2 viral load following vaccination. МedRxiv. 2021. doi:10.1101/2021.02.06.21251283</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Riemersma KK, Grogan BE, Kita-Yarbro A. Shedding of infectious SARS-CoV-2 despite vaccination. МedRxiv. 2021. doi:10.1101/2021.07.31.21261387</mixed-citation><mixed-citation xml:lang="en">Riemersma KK, Grogan BE, Kita-Yarbro A. Shedding of infectious SARS-CoV-2 despite vaccination. МedRxiv. 2021. doi:10.1101/2021.07.31.21261387</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Musser JM, Christensen PA, Olsen RJ. Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas. МedRxiv. 2021. doi:10.1101/2021.07.19.21260808</mixed-citation><mixed-citation xml:lang="en">Musser JM, Christensen PA, Olsen RJ. Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas. МedRxiv. 2021. doi:10.1101/2021.07.19.21260808</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Brown CM, Vostok J, Johnson H, et al. Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021. MMWR Morb Mortal Wkly Rep. 2021; 70:1059—62. doi:10.15585/mmwr.mm7031e2</mixed-citation><mixed-citation xml:lang="en">Brown CM, Vostok J, Johnson H, et al. Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021. MMWR Morb Mortal Wkly Rep. 2021; 70:1059—62. doi:10.15585/mmwr.mm7031e2</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Chia PY, Xiang Ong SW, Chiew CJ. Virological and serological kinetics of SARS-CoV-2 delta variant vaccine-breakthrough infections: a multi-center cohort study. МedRxiv. 2021. doi:10.1101/2021.07.28.21261295</mixed-citation><mixed-citation xml:lang="en">Chia PY, Xiang Ong SW, Chiew CJ. Virological and serological kinetics of SARS-CoV-2 delta variant vaccine-breakthrough infections: a multi-center cohort study. МedRxiv. 2021. doi:10.1101/2021.07.28.21261295</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Lavine JS, Bjornstad ON, Antia R. Immunological characteristics govern the transition of COVID-19 to endemicity. Science. 2021; 371:741—5. doi:10.1126/science.abe6522</mixed-citation><mixed-citation xml:lang="en">Lavine JS, Bjornstad ON, Antia R. Immunological characteristics govern the transition of COVID-19 to endemicity. Science. 2021; 371:741—5. doi:10.1126/science.abe6522</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Zimmermann P, Pittet LF, Finn A, Pollard AJ, Curtis N. Should children be vaccinated against COVID-19? Arch Dis Child. 2022 Mar; 107(3):e1. doi:10.1136/archdischild-2021-323040.</mixed-citation><mixed-citation xml:lang="en">Zimmermann P, Pittet LF, Finn A, Pollard AJ, Curtis N. Should children be vaccinated against COVID-19? Arch Dis Child. 2022 Mar; 107(3):e1. doi:10.1136/archdischild-2021-323040.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Our World in Data. COVID-19 vaccine doses administered. Available: https://ourworldindata.org/grapher/cumulative-covid-vaccinations [Accessed 24 Jul 2021].</mixed-citation><mixed-citation xml:lang="en">Our World in Data. COVID-19 vaccine doses administered. Available: https://ourworldindata.org/grapher/cumulative-covid-vaccinations [Accessed 24 Jul 2021].</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Frenck RW, Klein NP, Kitchin N, et al. Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. N Engl J Med. 2021; 385:239—50. doi:10.1056/NEJMoa2107456</mixed-citation><mixed-citation xml:lang="en">Frenck RW, Klein NP, Kitchin N, et al. Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. N Engl J Med. 2021; 385:239—50. doi:10.1056/NEJMoa2107456</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Castillo JC, Ahuja A, Athey S, et al. Market design to accelerate COVID-19 vaccine supply. Science. 2021; 371:1107—9. doi:10.1126/science.abg0889</mixed-citation><mixed-citation xml:lang="en">Castillo JC, Ahuja A, Athey S, et al. Market design to accelerate COVID-19 vaccine supply. Science. 2021; 371:1107—9. doi:10.1126/science.abg0889</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Coleman PG, Perry BD, Woolhouse ME. Endemic stability--a veterinary idea applied to human public health. Lancet. 2001; 357: 1284—6. doi:10.1016/S0140-6736(00)04410-X</mixed-citation><mixed-citation xml:lang="en">Coleman PG, Perry BD, Woolhouse ME. Endemic stability--a veterinary idea applied to human public health. Lancet. 2001; 357: 1284—6. doi:10.1016/S0140-6736(00)04410-X</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">UK joint Committee on vaccination and immunisation. JCVI statement on COVID-19 vaccination of children aged 12 to 15 years: 3 September 2021. Available: https://www.gov.uk/government/publications/jcvi-statementseptember-2021-covid-19-vaccination-of-children-aged-12-to15-years/jcvi-statement-on-covid-19-vaccination-of-childrenaged-12-to-15-years-3-september-2021 [Accessed 4 Oct 2021].</mixed-citation><mixed-citation xml:lang="en">UK joint Committee on vaccination and immunisation. JCVI statement on COVID-19 vaccination of children aged 12 to 15 years: 3 September 2021. Available: https://www.gov.uk/government/publications/jcvi-statementseptember-2021-covid-19-vaccination-of-children-aged-12-to15-years/jcvi-statement-on-covid-19-vaccination-of-childrenaged-12-to-15-years-3-september-2021 [Accessed 4 Oct 2021].</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Norwegian Institute of Public Health. 12—15-year-olds will be offered coronavirus vaccination. Available: https://www.fhi.no/en/news/2021/12-15-year-olds-will-be-offered-coronavirus-vaccination/ [Accessed 4 Oct 2021].</mixed-citation><mixed-citation xml:lang="en">Norwegian Institute of Public Health. 12—15-year-olds will be offered coronavirus vaccination. Available: https://www.fhi.no/en/news/2021/12-15-year-olds-will-be-offered-coronavirus-vaccination/ [Accessed 4 Oct 2021].</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
